AsymBio
AsymBio is a technology-driven CDMO with a global vision and best-in-class solutions for bioconjugates, antibodies, etc. We are capable of delivering bioconjugate IND projects in 13 months and BLA projects in 24 months. AsymBio is the innovative, reliable and client centric CDMO partner driven for your success in the competitive pharmaceutical landscape.